首页> 外国专利> COMPOSITION FOR DETECTING THE RESPONSE OF RECTAL ADENOCARCINOMAS TO RADIOCHEMOTHERAPY

COMPOSITION FOR DETECTING THE RESPONSE OF RECTAL ADENOCARCINOMAS TO RADIOCHEMOTHERAPY

机译:用于检测直肠腺癌对放射化学疗法的反应的组合物

摘要

A cDNA array (9984 genes) was used for expression profiling in rectal adenocarcinoma. The expression data were correlated to responsiveness to chemotherapy followed by radiotherapy. A set of 54 genes was found that were differentially expressed in responders vs. non-responders. The genes may be used as prognostic markers for determining whether a rectal adenocarcinoma is responsive to radiohemotherapy.
机译:使用cDNA阵列(9984个基因)在直肠腺癌中进行表达谱分析。表达数据与对化学疗法随后放疗的反应性相关。发现一组54个基因在应答者与非应答者中差异表达。该基因可用作确定直肠腺癌是否对放射线血液疗法有反应的预后标志物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号